Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery;Współczesne pogla̧dy na temat wykorzystania żelu bogatopłytkowego w ortopedii i traumatologii

Ortopedia Traumatologia Rehabilitacja

Volumn 9, Issue 3, 2007, Pages 227-238

  Wrotniak, Maciej ^a   Bielecki, Tomasz ^a   Gaździk, Tadeusz Szymon ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Healing; Infection; Non union; Platelet rich plasma; PRG

Indexed keywords

CALCIUM CHLORIDE; EPIDERMAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; THROMBIN; TRANSFORMING GROWTH FACTOR BETA;

CARTILAGE CELL; FRACTURE HEALING; GEL; HUMAN; MESENCHYMAL STEM CELL; MUSCULOSKELETAL SYSTEM; NONHUMAN; ORTHOPEDIC SURGERY; REVIEW; SOFT TISSUE; THROMBOCYTE RICH GEL; THROMBOCYTE RICH PLASMA; TRAUMATOLOGY;

CHONDROCYTES; FRACTURE HEALING; GELS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; SOFT TISSUE INJURIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 34948853832     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Bielecki T, Gaździk TS, Cieślik-Bielecka A, Ciélik T. Zastosowanie żelu bogatopłytkowego jako biomateriału stymuluja̧cego procesy regeneracji i reparacji tkanek. Inżynieria Biomateriałów 2004; 7 (34): 22-5.
2. Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997; 55 (11): 1294-9.
3. RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Goergeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 638-46.
4. Roldan JC, Jepsen S, Schmidt C, Knüppel H, Rueger DC, Acil Y, Terheyden H. Sinus floor augmentation with simultanous placement of dental implants in the presence of platelet - rich plasma or rekombinant human bone morphogrenetic protein - 7. Clin Oral Impl 2004; 15: 716-23.
5. Antonaides HN. Human platelet derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced sub-units. Proc Natl Acad Sci USA 1981; 78: 7314-7.
6. Bowen-Pope DF. Production of platelet derived growth factor like molecules reduced expression of platelet derived growth factor receptors accompany transformation bya wide spectrum of agents. Proc Natl Acad Sci USA 1984; 81: 2396-2400.
7. Johnson A. The C-cis gene encodes a precursor of the B chain of platelet derived growth factor. Embriol J 1984, 76: 921-8.
8. Caplan AI. Identyfication of transforming growth factor beta to family members present in bone-inductive protein purified bovine bone. Proc Natl Sci USA 1990; 87: 9843-7.
9. Roberts AB, Spron MB. Physiologic actions and clinical applications of transforming growth factor beta. Growth factors 1993; 8: 1-9.
10. Beck LS. One systemic administration of transforming growth factor - beta, reverses age or glucocorticoid - impared wound healing. J Clin Invest 1993; 93: 2841-9.
11. Canalis E. Insuline - like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 1989; 83: 60-5.
12. Greenlagh DG. The role of growth factors in wound healing. J Trauma 1996; 41: 159-67.
13. Hussain MZ. Wound microenvironment. Wound healing. Biochemical and clinical aspects. Philadelphia. Saunders 1991; 43: 162-196.
14. Knighton D, Silver I, Hunt TK. Regulation of wound healing angiogenesis: effect of oxygen gradient and inspired oxygen concentration. Surgery 1981; 90: 262-70.
15. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-50.
16. Caplan AI. Bone development and repair. Bioessay 1987; 6: 171-5.
17. Marx RE, Ehler W J, Pelg M. Mandibular and fascial reconstruction: rehabilitation of the head and neck cancer patient. Bone 1996; 19 (1): 595-625.
18. Mustoe TA, Purdy J, Gramates P, Deuel TF, Thomasen A, Pierce GF. Reversal of impaired wound healing in irradiated rats by platelet derived growth factor-BB: requirement of an active bone marrow. Am J Surg 1989; 158: 345-50.
19. Pierce GF, Tarpley J, Yanagihara D, Deuel TF. PDGF, TGF beta 1 and basic FGFin dermal wound healing: neovassel and matrix formation and cessation of repair. Am J Pathol 1992; 140: 1375-88.
20. Knighton DR, Oredsson S, Banda M, Hunt TK. Regulation of repair: hypoxic control of macrophage mediated angiogenesis. Soft and hard tissue repair. New York: Praeger; 1984: 41-9.
21. Dequeker J. Bone structure and function. IN: Klippel JH, Dieppe PA, editors. Rheumatology. Mosby; St. Louis: 1994. p. 7, 30.1-30.2.
22. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Peroiodontol 2000; 17: 1654-61.
23. Cieslik-Bielecka A, Bielecki T, Gaździk TS, Cieślik T. Using the platelet rich plasma in treatment in mandibular cyst. Int J Oral Maxillofac Surg 2005; 34: 162.
24. Cieślik-Bielecka A, Bielecki T, Gaździk TS, Cieślik T. Czynniki wzrostu zawarte w osoczu bogatopłytkowym jako autogennym materiale stymuluja̧cym procesy gojenia tkanki kostnej. Czas Stomatol 2006; 59 (7): 510-7.
25. Jensen TB, Rahbek O, Overgaard S, Soballe K. Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs. J Orthop Res 2004; 22 (3): 653-8.
26. Bielecki TM, Gaździk TS. Wczesne wyniki zastosowania żelu bogatopłytkowego w gojeniu ubytków kostnych. I Interdyscyplinarna Konferencja Naukowa, Warszawa. 3-4 czerwca 2004 r.
27. Bielecki TM, Gaździk TS, Szczepañski T. Platelet-rich gel as a biomaterial inducing local immune response. JBJS (23 November 2006) [http://www.jbjs.org.uk/cgi/eletters/88-B/9/1228]
28. Bielecki TM, Gazdzik TS, Szczepanski T. Letter re: "The effects of local platelet rich plasma delivery on diabetic fracture healing" What do we use: Platelet-rich plasma or platelet-rich gel? Bone 2006; 39 (6): 1388.
29. Lucarelli E, Beccheroni A, Donati D, Sangiorgi L, Cenacchi A, Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003; 24 (18): 3095-100.
30. Romin M, Declerin J, Heymanin D, Deschamps C, Passuti N. Usefulness of combining platelets with bone marrow cells on ceramic bone substitutes. J Bone Joint Surg 2004; 86: 47-48.
31. Lowery GL, Kulkarni S, Pennisi AE. Use of autologous growth factors in lumbar spinal fusion. Bone 1999; 2: 47-50.
32. Kitoh H, Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H, Katoh M, Ishiguro N. Transplantation of marrow-derived mesenchymal stem cells and platelet rich plasma during osteogenesis - a preliminary result of three cases. Bone 2004; 35: 892-8.
33. Bielecki TM, Gazdzik TS. Percutaneous injection of autogenous growth factors in patient with nonunion of the humerus. Acase report. J Orthopaedics 2006; 3 (3): 15.
34. Bielecki T. Prospektywna ocena wpływu autologicznego żelu bogatopłytkowego na procesy gojenia tkanki kostnej. Rozprawa doktorska. Śla̧ska Akademia Medyczna, Katowice, 2005.
35. Wilkins RM, Kelly CM, The effect of AlloMatrix injectable putty on the outcome of long bone applications. Orhopaedics 2003; 26: 567-70.
36. Connolloy JF. Ijectable bone marrow preparation to stimulate osteogenic repair. Clin Orthop 1995; 313; 8-18.
37. Healey JH, Zimmerman PA, Mc Donnel JM. Percutaneous autologous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Ortop 1990; 256: 280-285.
38. Heringou P, Poignard A, Beaujean F, Rouard H. Percutaneous bone marrow grafting for nonunion. J Bone J Surg Am 2005; 87: 1430-7.
39. Cieslik-Bielecka A, Bielecki T, Gazdzik TS, Cieslik T. Why the platelet-rich gel has antimicrobial activity? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 (3): 303-5.
40. Tang YQ, Yeaman MR, Selsted ME. Antimicrobial peptides from human platelets. Infect Immun 2002; 70: 6524-33.
41. Bielecki T, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enrich with growth factors and other active substances. In vitro study. J Bone J Surg Br 2007; 89: 417-20.